Cellectis S.A.

(CLLS) Trade

By |

Profile

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

Contact Information

Website: www.cellectis.com
Main Phone: +33 181691600
Address: 8 rue de la Croix Jarry
City / Town: Paris
Country: FR
Postal Code: 75013

Issuer Information

Exchange: NSD
CEO: Andre Choulika
Employees: 264

Equities News

Profile

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

Contact Information

Website: www.cellectis.com
Main Phone: +33 181691600
Address: 8 rue de la Croix Jarry
City / Town: Paris
Country: FR
Postal Code: 75013

Issuer Information

Exchange: NSD
CEO: Andre Choulika
Employees: 264

Equities News

$ 21.01 $ -1.15 (-5.19%)
Last Price 21.01 Change $ -1.15 Change % -5.19 Tick N/A
Bid 20.96 Bid Size 200.00 Ask 21.13 Ask Size 100.00
Open 21.84 High 22.08 Low 20.56 Prev Close 22.16
Last Trade Volume 193,926 52 Wk Hi 34.71 52 Wk Low 7.33
Market Cap 898.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 42,780,186.00 EPS (TTM) -1.62 PE Ratio -12.10 Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 47 47 47 47
Low Target Price Estimate 28 28 28 28
Mean Target Price Estimate 41.5 41.5 40.83 41.5
Standard Deviation 7.12 7.12 7.03 7.12
Date of Most Recent Estimate 06/12/18 06/11/18 05/25/18 06/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.57 1.57 1.57 1.57